TTrialPathMatch Me to Trials
← Back to trials
RecruitingChronic Insomnia Disorder

Comparing Acoustic Resonance Therapy (ART) vs. Cognitive Behavioral Therapy for Insomnia (CBT-I)

Eligible age

22+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to compare changes in sleep quality in patients with moderate to severe insomnia, in participants randomized to Cognitive Behavioral Therapy for Insomnia (CBT-I) arm versus those randomized to the SONU Headband Acoustic Resonance Therapy (ART) arm at end of treatment (6 weeks).

Sponsor: Mayo Clinic

You may qualify if…

  • ✓ Adult subjects, 22 years of age and older at screening
  • ✓ Moderate-to-severe insomnia disorder, as defined by the International Classification of Sleep Disorders (ICSD-3)\* and the Insomnia Severity Index (ISI) and have been diagnosed for more than three months.
  • ✓ Not pregnant by subject self-report at time of consent.
  • ✓ Have the ability to provide informed consent.
  • ✓ Have the ability to complete all aspects of this trial.
  • ✓ Have access to an iOS mobile device (iPhone X or above).
  • ✓ Have no contraindicating comorbid health condition that would interfere with the proper use of the SONU Headband system, as determined by the clinical investigators.
  • ✓ Participants who are taking sleep-aiding pills must agree to no changes to medication and dosage during the study.

You may not qualify if…

  • ✕ Patients who are unable to commit to avoiding the consumption of alcohol during the study.
  • ✕ Patients who are unable to commit to avoid consumption of caffeine after 12 pm (noon).
  • ✕ Patients who have a clinically significant or unstable medical or surgical condition.
  • ✕ Participants using pacemakers or cardiac monitors.
  • ✕ Participants with severe physical illness or immediately post-surgery
  • ✕ Participants with severe mental disorders, such as schizophrenia, severe major depression, severe anxiety, bipolar disorder, dementia, substance use disorder, or severe neurological diseases such as a seizure, stroke, or Parkinson's disease.
  • ✕ Participants with other serious sleep disorders, such as severe obstructive sleep apnea.
  • ✕ Participants who are unable to attend regular follow-up evaluations.

Where it's recruiting

Minnesota

Rochester

Source: ClinicalTrials.gov · NCT07486882 · last updated 2026-03-23